Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

V W Armstrong

Showing results (131-140 of 145) with videos related to

Pageof 15
Sort By:
Therapeutic Drug Monitoring|December 1, 1995
Lake Louise Consensus Conference on cyclosporin monitoring in organ transplantation: report of the consensus panelM Oellerich, V W Armstrong, B Kahan, et al.
Therapeutic Drug Monitoring|January 8, 1998
Pitfalls in monitoring tacrolimus (FK 506)F Braun, E Schütz, U Christians, et al.
Transplantation Proceedings|December 1, 1996
Clinical relevance of monitoring tacrolimus: comparison of microparticle enzyme immunoassay, enzyme-linked immunosorbent assay, and liquid chromatography mass spectrometry in renal transplant recipients converted from cyclosporine to tacrolimusF Braun, T Lorf, E Schütz, et al.
Transplantation Proceedings|June 24, 1998
Therapeutic drug monitoring of mycophenolic acid: comparison of HPLC and immunoassay reveals new MPA metabolitesE Schütz, M Shipkova, V W Armstrong, et al.
The American Journal of Medicine|June 6, 1994
Treatment of primary hypercholesterolemia: fluvastatin versus bezafibrateH Greten, F U Beil, J Schneider, et al.
European Journal of Clinical Pharmacology|January 26, 2012
Inosine monophosphate dehydrogenase activity in paediatrics: age-related regulation and response to mycophenolic acidA Rother, P Glander, E Vitt, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|August 27, 1999
Pharmacokinetics of mycophenolic acid (MPA) and free MPA in paediatric renal transplant recipients--a multicentre study. The German Study Group on Mycophenolate Mofetil (MMF) TherapyL T Weber, E Schütz, T Lamersdorf, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|August 27, 1999
Therapeutic drug monitoring of total and free mycophenolic acid (MPA) and limited sampling strategy for determination of MPA-AUC in paediatric renal transplant recipients. The German Study Group on Mycophenolate Mofetil (MMF) TherapyL T Weber, E Schütz, T Lamersdorf, et al.
Transplantation Proceedings|June 24, 1998
Limited sampling strategy for the determination of mycophenolic acid area under the curve in pediatric kidney recipients. German Study Group on MMF Therapy in Pediatric Renal Transplant RecipientsE Schütz, V W Armstrong, M Shipkova, et al.
Transplantation Proceedings|November 15, 2002
Mycophenolate mofetil for the prophylaxis of acute graft-versus-host disease in stem cell transplant recipientsM G Kiehl, K Schäfer-Eckart, M Kröger, et al.
Pageof 15

Showing results (131-140 of 145) with videos related to

Sort By:
Pageof 15
Therapeutic Drug Monitoring|December 1, 1995
Lake Louise Consensus Conference on cyclosporin monitoring in organ transplantation: report of the consensus panelM Oellerich, V W Armstrong, B Kahan, et al.
Therapeutic Drug Monitoring|January 8, 1998
Pitfalls in monitoring tacrolimus (FK 506)F Braun, E Schütz, U Christians, et al.
Transplantation Proceedings|December 1, 1996
Clinical relevance of monitoring tacrolimus: comparison of microparticle enzyme immunoassay, enzyme-linked immunosorbent assay, and liquid chromatography mass spectrometry in renal transplant recipients converted from cyclosporine to tacrolimusF Braun, T Lorf, E Schütz, et al.
Transplantation Proceedings|June 24, 1998
Therapeutic drug monitoring of mycophenolic acid: comparison of HPLC and immunoassay reveals new MPA metabolitesE Schütz, M Shipkova, V W Armstrong, et al.
The American Journal of Medicine|June 6, 1994
Treatment of primary hypercholesterolemia: fluvastatin versus bezafibrateH Greten, F U Beil, J Schneider, et al.
European Journal of Clinical Pharmacology|January 26, 2012
Inosine monophosphate dehydrogenase activity in paediatrics: age-related regulation and response to mycophenolic acidA Rother, P Glander, E Vitt, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|August 27, 1999
Pharmacokinetics of mycophenolic acid (MPA) and free MPA in paediatric renal transplant recipients--a multicentre study. The German Study Group on Mycophenolate Mofetil (MMF) TherapyL T Weber, E Schütz, T Lamersdorf, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|August 27, 1999
Therapeutic drug monitoring of total and free mycophenolic acid (MPA) and limited sampling strategy for determination of MPA-AUC in paediatric renal transplant recipients. The German Study Group on Mycophenolate Mofetil (MMF) TherapyL T Weber, E Schütz, T Lamersdorf, et al.
Transplantation Proceedings|June 24, 1998
Limited sampling strategy for the determination of mycophenolic acid area under the curve in pediatric kidney recipients. German Study Group on MMF Therapy in Pediatric Renal Transplant RecipientsE Schütz, V W Armstrong, M Shipkova, et al.
Transplantation Proceedings|November 15, 2002
Mycophenolate mofetil for the prophylaxis of acute graft-versus-host disease in stem cell transplant recipientsM G Kiehl, K Schäfer-Eckart, M Kröger, et al.
Pageof 15